Results 31 to 40 of about 5,346,158 (173)

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) [PDF]

, 2018
Review on Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), with data on clinics, and the genes ...
Meloni-Ehrig, Aurelia
core   +1 more source

Cytoplasmic nucleophosmin is not detected in blastic plasmacytoid dendritic cell neoplasm

Haematologica, 2009
Acute myeloid leukemia carrying cytoplasmic mutated nucleophosmin (NPMc+ AML) and blastic plasmacytoid dendritic cell neoplasm have been included as new entities in the 4th edition (2008) WHO classification of myeloid neoplasms. These conditions may show
Fabio Facchetti, Stefano A. Pileri, Claudio Agostinelli, Maria Paola Martelli, Marco Paulli, Adriano Venditti, Massimo F Martelli, Brunangelo Falini   +7 more
doaj   +1 more source

Blastic Plasmacytoid Dendritic Cell Neoplasm

Current Treatment Options in Oncology, 2019
While there is a high initial response rate with standard chemotherapeutic regimens for blastic plasmacytoid dendritic cell neoplasm (BPDCN), the responses are typically not durable and this remains a very aggressive disease with generally poor outcomes.
Daniel, Kerr, Ling, Zhang, Lubomir, Sokol   +2 more
  +7 more sources

A Case of Blastic Plasmacytoid Dendritic Cell Neoplasm [PDF]

Annals of Dermatology, 2012
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare, highly aggressive hematopoietic malignancy that is characterized by cutaneous and bone marrow involvement and leukemic spread, representing 0.7% of primary cutaneous lymphomas1. Formerly known as CD4+/CD56+ hematodermic neoplasm or blastic NK-cell lymphoma2, BPDCN is derived from ...
Pinto-Almeida, Teresa, Fernandes, Iolanda, Sanches, Madalena, Lau, Catarina, Lima, Margarida, Alves, Rosário, Selores, Manuela   +6 more
openaire   +2 more sources

Blastic plasmacytoid dendritic cell neoplasm presenting as violaceous forehead plaque [PDF]

, 2022
A 72-year-old man with a history of squamous cell carcinoma presented to the Portland VA with forehead discoloration. He was initially diagnosed with actinic damage and prescribed topical treatment.
Hopkins, Amy, Scopetta, John P, Knapp, Calvin, Kulkarni, Raj, Morrison, Georgia Mae   +4 more
core   +1 more source

Blastic Plasmacytoid Dendritic cell neoplasm: Case report / Neoplasia de células Dendríticas Plasmocitóides Blásticas: Relato de caso [PDF]

, 2021
Blastic plasmacytoid dendritic cell neoplasm is a rare neoplasm of hematopoietic origin with poor clinical evolution. Here we report a case of a patient who presented with blastic plamacytoid dendritic cell neoplasm with cutaneous and nodal involvement ...
Sallum, Michel Hamui, de Souza, Helio Moraes, da Silva, Vanessa Afonso, de Vito, Fernanda Bernadelli   +3 more
core   +1 more source

Blastic plasmacytoid dendritic cell neoplasm of the uterus [PDF]

Srpski Arhiv za Celokupno Lekarstvo, 2020
Introduction. Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and very aggressive hematological malignancy derived from precursor of the plasmacytoid dendritic cell.
Đurđević Predrag, Todorović Željko, Jovanović Danijela, Čekerevac Ivan, Novković Ljiljana, Mitrović Slobodanka, Čemerikić Vesna, Otašević Vladimir, Antić Darko   +8 more
doaj   +1 more source

Treatment of blastic plasmacytoid dendritic cell neoplasm [PDF]

Hematology, 2016
Abstract Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare myeloid malignancy with no defined standard of care. BPDCN presents most commonly with skin lesions with or without extramedullary organ involvement before leukemic dissemination.
Jill M, Sullivan, David A, Rizzieri
openaire   +2 more sources

Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition.

, 2014
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare disease of controversial origin recently recognized as a neoplasm deriving from plasmacytoid dendritic cells (pDCs).
Pileri A. Jr, Gazzola A, Rossi M, Cerroni L, FACCHETTI, Fabio, Arpinati M, Santucci M, Fuligni F, for the AIRC 5xMille consortium ‘Genetics driven targeted management of lymphoid malignancies’, the Italian Registry on Blastic Plasmacytoid Dendritic Cell Neoplasm, Agostinelli C, Sapienza MR, GIBELLINI, Davide, Gibellini D, Laginestra MA, Mannu C, Maeda T, Croce CM, Tripodo C, Pileri SA, Righi S, Ulbar F, Melle F, Pagano L, Paulli M, Ricci F, Piccaluga PP, Facchetti F, Mancini M, Pimpinelli N   +29 more
core   +3 more sources

Venetoclax in relapsed/refractory blastic plasmacytoid dendritic cell neoplasm with central nervous system involvement: a case report and review of the literature

Journal of Medical Case Reports, 2021
Background We describe a patient with blastic plasmacytoid dendritic cell neoplasm with central nervous system involvement and the outcome of venetoclax use in this setting.
Nil Albiol, Silvana Novelli, Anna Mozos, Marta Pratcorona, Rodrigo Martino, Jorge Sierra   +5 more
doaj   +1 more source